<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/55D627C6-C257-4357-89BF-D60EE9171ED4"><gtr:id>55D627C6-C257-4357-89BF-D60EE9171ED4</gtr:id><gtr:firstName>Quentin</gtr:firstName><gtr:otherNames>Mark</gtr:otherNames><gtr:surname>Anstee</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G84%2F6233"><gtr:id>8BA6A5FF-F11E-43D2-BE38-B38A5E46671B</gtr:id><gtr:title>Genetic characterisation of a novel mouse model of Non-Alcoholic Fatty Liver Disease generated using ENU mutagenesis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G84/6233</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>154279</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Neuroscience</gtr:department><gtr:description>MRC Alcomouse Project</gtr:description><gtr:id>D509C34F-4E0B-46B8-921B-EE59C3F5CD75</gtr:id><gtr:impact>Abstracts published, full manuscript in preparation for submission autumn 2010.</gtr:impact><gtr:outcomeId>cd9hbHrMjyA-2</gtr:outcomeId><gtr:partnerContribution>Collaboration characterising functional consequences of ENU induced mutations in miceElectrophysiological (brain slice) studies of GABA receptor function in ENU mutant miceIn vitro electrophysiological studies of GABA functionLong standing collaboration with the unit in which I have worked until my recent promotion and transfer to Newcastle University</gtr:partnerContribution><gtr:piContribution>Development of high alcohol consuming mice models of addiction induced by single base-pair changes caused by ENU mutagenesis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Clinical Pharmacology &amp; Therapeutics</gtr:department><gtr:description>MRC Alcomouse Project</gtr:description><gtr:id>78310F5F-0D7A-4898-A0CF-542C87CC992C</gtr:id><gtr:impact>Abstracts published, full manuscript in preparation for submission autumn 2010.</gtr:impact><gtr:outcomeId>cd9hbHrMjyA-3</gtr:outcomeId><gtr:partnerContribution>Collaboration characterising functional consequences of ENU induced mutations in miceElectrophysiological (brain slice) studies of GABA receptor function in ENU mutant miceIn vitro electrophysiological studies of GABA functionLong standing collaboration with the unit in which I have worked until my recent promotion and transfer to Newcastle University</gtr:partnerContribution><gtr:piContribution>Development of high alcohol consuming mice models of addiction induced by single base-pair changes caused by ENU mutagenesis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Medical and Dental Sciences</gtr:department><gtr:description>MRC 'UK GoLD' (UK Genetics of Liver Disease) Consortium</gtr:description><gtr:id>8DB01F8A-0F1E-4ACF-B36B-3891F5B2737F</gtr:id><gtr:impact>The IMPC has just been established (October 2011).</gtr:impact><gtr:outcomeId>SoNgdVBTeUw-2</gtr:outcomeId><gtr:partnerContribution>ExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertise</gtr:partnerContribution><gtr:piContribution>I am Principle Investigator of the 'UK GoLD' (UK Genetics of Liver Disease) consortium which has been awarded MRC Mouse Phenotyping Network status and will be advising and using specific gene knockout mice produced as part of the International Mouse Phenotyping Consortium (IMPC) to further research into addiction behaviour and genetic modifiers of liver disease and liver fibrosis. Members of the UK GoLD consortium are be from University of Newcastle, University of Dundee, UCL, Imperial, University of Sussex, University of Birmingham, Cambridge University and MRC Harwell.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Harwell</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Mammalian Genetics Unit</gtr:department><gtr:description>MRC Harwell - Liver Research programme</gtr:description><gtr:id>10632AEF-4931-4FF0-88D2-9525899497E8</gtr:id><gtr:impact>This collaboration has lead to the identification of novel murine models of NAFLD/NASH, Alcohol Addiction and Drug Induced Liver Injury. Some of these have already been published and manuscripts describing others are in preparation.</gtr:impact><gtr:outcomeId>01CA58FBC15-1</gtr:outcomeId><gtr:partnerContribution>Long standing collaboration since my training fellowship with Professors Roger Cox and Steve Brown. Long standing collaboration with colleagueswith whome I worked up-until my recent promotion and move to Newcastle University.</gtr:partnerContribution><gtr:piContribution>Following completion of my fellowship and PhD I became a Clinical Lecturer at Imperial College and am an Honorary Group Leader at MRC Harwell where I lead the joint Imperial-MRC Liver Research Programme within the Metabolism &amp;amp; Inflammation Section of the MGU.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biosciences</gtr:department><gtr:description>MRC 'UK GoLD' (UK Genetics of Liver Disease) Consortium</gtr:description><gtr:id>7AC89625-3B22-4A9A-A23B-357A882035BC</gtr:id><gtr:impact>The IMPC has just been established (October 2011).</gtr:impact><gtr:outcomeId>SoNgdVBTeUw-4</gtr:outcomeId><gtr:partnerContribution>ExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertise</gtr:partnerContribution><gtr:piContribution>I am Principle Investigator of the 'UK GoLD' (UK Genetics of Liver Disease) consortium which has been awarded MRC Mouse Phenotyping Network status and will be advising and using specific gene knockout mice produced as part of the International Mouse Phenotyping Consortium (IMPC) to further research into addiction behaviour and genetic modifiers of liver disease and liver fibrosis. Members of the UK GoLD consortium are be from University of Newcastle, University of Dundee, UCL, Imperial, University of Sussex, University of Birmingham, Cambridge University and MRC Harwell.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sussex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Psychology Sussex</gtr:department><gtr:description>MRC Alcomouse Project</gtr:description><gtr:id>5C5DFD06-9AB0-4564-AB70-1A0A1E799080</gtr:id><gtr:impact>Abstracts published, full manuscript in preparation for submission autumn 2010.</gtr:impact><gtr:outcomeId>cd9hbHrMjyA-1</gtr:outcomeId><gtr:partnerContribution>Collaboration characterising functional consequences of ENU induced mutations in miceElectrophysiological (brain slice) studies of GABA receptor function in ENU mutant miceIn vitro electrophysiological studies of GABA functionLong standing collaboration with the unit in which I have worked until my recent promotion and transfer to Newcastle University</gtr:partnerContribution><gtr:piContribution>Development of high alcohol consuming mice models of addiction induced by single base-pair changes caused by ENU mutagenesis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Cellular Medicine</gtr:department><gtr:description>'FLIP' Fatty Liver Inhibition of Progression (EU FP7 Funded Research Programme)</gtr:description><gtr:id>529B150F-0375-4973-ACF7-286887CB56AA</gtr:id><gtr:impact>Ongoing collaboration</gtr:impact><gtr:outcomeId>krFuozML4Bg-1</gtr:outcomeId><gtr:partnerContribution>Expertise and Clinical SamplesExpertise and Clinical Samples</gtr:partnerContribution><gtr:piContribution>The EU FP7 funded 'FLIP' programme is an international collaboration to research Non-Alcoholic Fatty Liver Disease. With colleagues in Newcastle (Prof C. Day and Prof A. Daly) I am coordinating the genetics work package which is undertaking the largest GWAS of biopsy proven fatty liver disease so far performed.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>MRC Alcomouse Project</gtr:description><gtr:id>D0DEB7C7-8EE1-4AFF-8D18-11F3653B1F9D</gtr:id><gtr:impact>Abstracts published, full manuscript in preparation for submission autumn 2010.</gtr:impact><gtr:outcomeId>cd9hbHrMjyA-4</gtr:outcomeId><gtr:partnerContribution>Collaboration characterising functional consequences of ENU induced mutations in miceElectrophysiological (brain slice) studies of GABA receptor function in ENU mutant miceIn vitro electrophysiological studies of GABA functionLong standing collaboration with the unit in which I have worked until my recent promotion and transfer to Newcastle University</gtr:partnerContribution><gtr:piContribution>Development of high alcohol consuming mice models of addiction induced by single base-pair changes caused by ENU mutagenesis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>MRC Harwell - Liver Research programme</gtr:description><gtr:id>895D53A0-4747-497B-AF4D-42EFDB089106</gtr:id><gtr:impact>This collaboration has lead to the identification of novel murine models of NAFLD/NASH, Alcohol Addiction and Drug Induced Liver Injury. Some of these have already been published and manuscripts describing others are in preparation.</gtr:impact><gtr:outcomeId>01CA58FBC15-2</gtr:outcomeId><gtr:partnerContribution>Long standing collaboration since my training fellowship with Professors Roger Cox and Steve Brown. Long standing collaboration with colleagueswith whome I worked up-until my recent promotion and move to Newcastle University.</gtr:partnerContribution><gtr:piContribution>Following completion of my fellowship and PhD I became a Clinical Lecturer at Imperial College and am an Honorary Group Leader at MRC Harwell where I lead the joint Imperial-MRC Liver Research Programme within the Metabolism &amp;amp; Inflammation Section of the MGU.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sussex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Psychology Sussex</gtr:department><gtr:description>MRC 'UK GoLD' (UK Genetics of Liver Disease) Consortium</gtr:description><gtr:id>671214C8-800C-4EF5-A7DA-D713301F379F</gtr:id><gtr:impact>The IMPC has just been established (October 2011).</gtr:impact><gtr:outcomeId>SoNgdVBTeUw-5</gtr:outcomeId><gtr:partnerContribution>ExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertise</gtr:partnerContribution><gtr:piContribution>I am Principle Investigator of the 'UK GoLD' (UK Genetics of Liver Disease) consortium which has been awarded MRC Mouse Phenotyping Network status and will be advising and using specific gene knockout mice produced as part of the International Mouse Phenotyping Consortium (IMPC) to further research into addiction behaviour and genetic modifiers of liver disease and liver fibrosis. Members of the UK GoLD consortium are be from University of Newcastle, University of Dundee, UCL, Imperial, University of Sussex, University of Birmingham, Cambridge University and MRC Harwell.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Brain Sciences</gtr:department><gtr:description>MRC 'UK GoLD' (UK Genetics of Liver Disease) Consortium</gtr:description><gtr:id>26BDE02C-CAA2-47BE-9E81-AAD34E146E95</gtr:id><gtr:impact>The IMPC has just been established (October 2011).</gtr:impact><gtr:outcomeId>SoNgdVBTeUw-3</gtr:outcomeId><gtr:partnerContribution>ExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertise</gtr:partnerContribution><gtr:piContribution>I am Principle Investigator of the 'UK GoLD' (UK Genetics of Liver Disease) consortium which has been awarded MRC Mouse Phenotyping Network status and will be advising and using specific gene knockout mice produced as part of the International Mouse Phenotyping Consortium (IMPC) to further research into addiction behaviour and genetic modifiers of liver disease and liver fibrosis. Members of the UK GoLD consortium are be from University of Newcastle, University of Dundee, UCL, Imperial, University of Sussex, University of Birmingham, Cambridge University and MRC Harwell.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Neuroscience</gtr:department><gtr:description>MRC 'UK GoLD' (UK Genetics of Liver Disease) Consortium</gtr:description><gtr:id>34DADB28-1BA0-47B5-9BE3-E0FAAA2D28BE</gtr:id><gtr:impact>The IMPC has just been established (October 2011).</gtr:impact><gtr:outcomeId>SoNgdVBTeUw-1</gtr:outcomeId><gtr:partnerContribution>ExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertise</gtr:partnerContribution><gtr:piContribution>I am Principle Investigator of the 'UK GoLD' (UK Genetics of Liver Disease) consortium which has been awarded MRC Mouse Phenotyping Network status and will be advising and using specific gene knockout mice produced as part of the International Mouse Phenotyping Consortium (IMPC) to further research into addiction behaviour and genetic modifiers of liver disease and liver fibrosis. Members of the UK GoLD consortium are be from University of Newcastle, University of Dundee, UCL, Imperial, University of Sussex, University of Birmingham, Cambridge University and MRC Harwell.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Cellular Medicine</gtr:department><gtr:description>MRC 'UK GoLD' (UK Genetics of Liver Disease) Consortium</gtr:description><gtr:id>26CDBAB1-3A54-4D17-96B9-EDED47D36E8C</gtr:id><gtr:impact>The IMPC has just been established (October 2011).</gtr:impact><gtr:outcomeId>SoNgdVBTeUw-6</gtr:outcomeId><gtr:partnerContribution>ExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertise</gtr:partnerContribution><gtr:piContribution>I am Principle Investigator of the 'UK GoLD' (UK Genetics of Liver Disease) consortium which has been awarded MRC Mouse Phenotyping Network status and will be advising and using specific gene knockout mice produced as part of the International Mouse Phenotyping Consortium (IMPC) to further research into addiction behaviour and genetic modifiers of liver disease and liver fibrosis. Members of the UK GoLD consortium are be from University of Newcastle, University of Dundee, UCL, Imperial, University of Sussex, University of Birmingham, Cambridge University and MRC Harwell.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Harwell</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Mammalian Genetics Unit</gtr:department><gtr:description>MRC 'UK GoLD' (UK Genetics of Liver Disease) Consortium</gtr:description><gtr:id>031133CC-4969-4ED6-B5CE-9BC425B65822</gtr:id><gtr:impact>The IMPC has just been established (October 2011).</gtr:impact><gtr:outcomeId>SoNgdVBTeUw-8</gtr:outcomeId><gtr:partnerContribution>ExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertise</gtr:partnerContribution><gtr:piContribution>I am Principle Investigator of the 'UK GoLD' (UK Genetics of Liver Disease) consortium which has been awarded MRC Mouse Phenotyping Network status and will be advising and using specific gene knockout mice produced as part of the International Mouse Phenotyping Consortium (IMPC) to further research into addiction behaviour and genetic modifiers of liver disease and liver fibrosis. Members of the UK GoLD consortium are be from University of Newcastle, University of Dundee, UCL, Imperial, University of Sussex, University of Birmingham, Cambridge University and MRC Harwell.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Addenbrooke's Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Hepatology Clinic</gtr:department><gtr:description>MRC 'UK GoLD' (UK Genetics of Liver Disease) Consortium</gtr:description><gtr:id>D140D186-906B-498E-8D2D-80270A901D7C</gtr:id><gtr:impact>The IMPC has just been established (October 2011).</gtr:impact><gtr:outcomeId>SoNgdVBTeUw-7</gtr:outcomeId><gtr:partnerContribution>ExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertiseExpertise</gtr:partnerContribution><gtr:piContribution>I am Principle Investigator of the 'UK GoLD' (UK Genetics of Liver Disease) consortium which has been awarded MRC Mouse Phenotyping Network status and will be advising and using specific gene knockout mice produced as part of the International Mouse Phenotyping Consortium (IMPC) to further research into addiction behaviour and genetic modifiers of liver disease and liver fibrosis. Members of the UK GoLD consortium are be from University of Newcastle, University of Dundee, UCL, Imperial, University of Sussex, University of Birmingham, Cambridge University and MRC Harwell.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BASL 2007</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CFFAE5A1-76B5-4AE8-B72A-10164486EC9F</gtr:id><gtr:impact>An invited lecture on mouse models of NAFLD at the British Association for the Study of the Liver.

Wider collaboration</gtr:impact><gtr:outcomeId>0D88C0A760A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AASLD 2008</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3A6BB5B3-EF83-453C-A59F-04AFC800EC23</gtr:id><gtr:impact>Oral presentation describing a new model of alcohol dependence generated by ENU mutagenesis

Dissemination of data</gtr:impact><gtr:outcomeId>3D09A3517A1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AASLD 2006</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A0651DC9-FC01-4F4B-84C1-B3DE1E9E79F7</gtr:id><gtr:impact>Oral presentation on results microarray analysis in a new model of NAFLD

Dissemination of data</gtr:impact><gtr:outcomeId>D6C8F1229BE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EASL 2007</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DAABFAB1-6E32-4B4F-AB2C-6CC9CA3F4F45</gtr:id><gtr:impact>Poster presentation of data on microarray analysis of NAFLD model. Won prize for best research poster presented.

Dissemination of data</gtr:impact><gtr:outcomeId>038C003247D</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Harwell Website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C73F14DF-386F-45A3-A3A2-623695500F03</gtr:id><gtr:impact>Website &amp;amp; Press Release

Public information</gtr:impact><gtr:outcomeId>CE49BDA0CD5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media interest (Alcomouse)</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>59077027-4A25-4A4C-B664-A5FABC066E7B</gtr:id><gtr:impact>Following the publication of &amp;quot;Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibition&amp;quot; Anstee et al (Nature Communications, 2013) there was substantial media interest in the work. A joint-press release between Newcastle University and the MRC was made which attracted &amp;gt;60,000 visits to the Newcastle University website. The research was publicised in the UK media (The Times, Telegraph, Independent, Daily Express, etc), ITV News, UK national radio stations and internationally on TV, radio, print media and Internet (Brazil, USA, Europe).

Massive interest in the genetic basis of alcohol addiction</gtr:impact><gtr:outcomeId>545a72ed72dba8.36679090</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Coagulation in Liver Disease 2007</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4768D9AC-DE04-4CC6-8C69-DC2A07A0D983</gtr:id><gtr:impact>An invited lecture on the interaction between coagulation/thrombin and hepatic fibrosis.

Wider disemination of work.</gtr:impact><gtr:outcomeId>050795F1F6C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BASL 2008</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>71A738AA-A164-4829-AC79-E1A6F44D3368</gtr:id><gtr:impact>Oral presentation describing a new model of alcohol dependence generated by ENU mutagenesis. Won prize for Best Research presented at meeting.

Dissemination of data</gtr:impact><gtr:outcomeId>0AAA3F68552</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Coagulation in Liver Disease 2009</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7404D34F-BDDF-437D-95AF-790264FF76C9</gtr:id><gtr:impact>Invited lecture at conference

New collaborations and dissemination of research findings.</gtr:impact><gtr:outcomeId>B85920D90B0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AASLD 2009</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E4252EC4-E80C-4096-9A77-A0DC96324BFE</gtr:id><gtr:impact>Dissemination at International Meeting

Interest and potential for future collaborations</gtr:impact><gtr:outcomeId>kysRWJAr6Uq</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Television - Horizon</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>329E426E-3482-42C2-BB9F-989C19B13EF6</gtr:id><gtr:impact>Partcipated in a BBC Television documentary (Horizon) on the impact of the human genome project. Broadcast October 2010.

Increased awareness in general public</gtr:impact><gtr:outcomeId>RNvUT7sWrjA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EASL 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0D7A55A5-01B0-4462-96CE-CD61FE37389B</gtr:id><gtr:impact>Interest in Research Activity

Potential future collaborations</gtr:impact><gtr:outcomeId>EthGq3HAB2t</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EASL 2011</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0BC08B49-2A9B-4EB9-9C12-FD1010A0998E</gtr:id><gtr:impact>Presentation of research at an International Conference

Dissemination and new collaborations</gtr:impact><gtr:outcomeId>n4XpY1JM7gc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EF5FD235-72A2-46BA-9C10-F762DA7D9488</gtr:id><gtr:impact>Participated in 'Health in the Headlines', an invited panel discussion with Professors Robert Winston &amp;amp; Chris Ponting
The Times Cheltenham Science Festival 2010


Lots of interest in my research into ENU mutagenesis and the role of genes in liver disease and addiction.</gtr:impact><gtr:outcomeId>dhXiwamveF6</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant (Co-Investigator)</gtr:description><gtr:end>2011-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G06/00725</gtr:fundingRef><gtr:id>1F06ECE8-4C45-422D-9096-A9C1B9AC4EA3</gtr:id><gtr:outcomeId>581A6C1C44C0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EU Horizon 2020</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>634413 - EPoS - RIA</gtr:fundingRef><gtr:id>D3E7EC8D-7558-422B-9D26-9B63A4D7D67D</gtr:id><gtr:outcomeId>56b695c6281293.94521167</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome/Academy of Medical Sciences Clinical Lecturer Starter Grant (Mentored Investigator)</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>A8C5CADA-A78C-4639-8BEB-0164F32D05A0</gtr:id><gtr:outcomeId>47CA037EF670</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HEFCE Clinical Senior Lecturer Award</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Higher Education Funding Council for England (HEFCE)</gtr:fundingOrg><gtr:id>8898806B-7DE5-4F3E-BD22-0F0C01F98446</gtr:id><gtr:outcomeId>mWFXkvk3UMh0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>23000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Vertex Research Grant (Co-Investigator)</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>Vertex Pharmaceuticals</gtr:fundingOrg><gtr:id>36583A06-A166-433B-9B2D-4D51B2143C68</gtr:id><gtr:outcomeId>4DC4BBF91480</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Imperial Biomedical Research Centre</gtr:department><gtr:description>Imperial College - NIHR Biomedical Research Centre Grant (Co-Investigator)</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>7FE96972-DA7D-48DC-BB32-F40F0E35354E</gtr:id><gtr:outcomeId>C72AE22682E0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Anticoagulation to slow Liver Fibrosis</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5FD87C54-2822-4CEE-B819-CD2B4F215C5F</gtr:id><gtr:outcomeId>F46EA9C8A67</gtr:outcomeId><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>MRC UK Genetics of Liver Disease (UK GoLD) Consortium</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>110CC7D2-6356-495A-BEA5-C2065D32916A</gtr:id><gtr:outcomeId>omkTDebjfd8</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>The use of warfarin, a well established anticoagulant, to slow progression of liver fibrosis in chronic hepatitis C infection.</gtr:description><gtr:id>AB2B891A-333B-4548-B917-00A8410B4288</gtr:id><gtr:impact>The use of this drug is the subject of an ongoing MRC Experimental Medicine funded clinical trial to determine efficacy in slowing the accelerated liver fibrosis encountered post-liver transplant in chronic hepatitis C infection.</gtr:impact><gtr:outcomeId>AB93038A9C1</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Anticoagulation to slow Liver Fibrosis</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2008</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1636B0B4-0EB6-4A0B-9CDE-A6CA39C7822C</gtr:id><gtr:title>How big a problem is non-alcoholic fatty liver disease?</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24c89a46bc4fc9d556fe9b4dc2be9826"><gtr:id>24c89a46bc4fc9d556fe9b4dc2be9826</gtr:id><gtr:otherNames>Anstee QM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>NNdKppzomSW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB082B93-C2D8-4B3E-9FD5-D8C37C20628D</gtr:id><gtr:title>Role of monocytes and macrophages in experimental and human acute liver failure.</gtr:title><gtr:parentPublicationTitle>World journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eee8b47b413a4ed31c63b33f6107a7c2"><gtr:id>eee8b47b413a4ed31c63b33f6107a7c2</gtr:id><gtr:otherNames>Possamai LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1007-9327</gtr:issn><gtr:outcomeId>Lv7JJqfSAK5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>342A3793-7739-40D0-9458-2718B45FBD3D</gtr:id><gtr:title>Hypercoagulation and thrombophilia in liver disease.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85ed88526429f6dec437b746c7b2cad5"><gtr:id>85ed88526429f6dec437b746c7b2cad5</gtr:id><gtr:otherNames>Northup PG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>C48FA0422FF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCDED704-761B-47EB-B2B8-45EE35F1EAF4</gtr:id><gtr:title>Investigating mildly abnormal serum aminotransferase values.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2b41ed5756913a8115ec4ee278021cd"><gtr:id>b2b41ed5756913a8115ec4ee278021cd</gtr:id><gtr:otherNames>Cobbold JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>5a6f53010dd0f2.25363035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8248064-4C6B-42B4-81DE-5721BCC89655</gtr:id><gtr:title>Multi-excitation fluorescence spectroscopy for analysis of non-alcoholic fatty liver disease.</gtr:title><gtr:parentPublicationTitle>Lasers in surgery and medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e830bef132e24cdc97bd6acecea60ba"><gtr:id>2e830bef132e24cdc97bd6acecea60ba</gtr:id><gtr:otherNames>Sauvage VR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0196-8092</gtr:issn><gtr:outcomeId>KsCCn6apxrK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A864D79C-DE87-4D07-8989-E0015536C0A6</gtr:id><gtr:title>Hypercoagulability in cirrhosis: causes and consequences.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cae21a7acabc640bb0f38cfdc8bb296c"><gtr:id>cae21a7acabc640bb0f38cfdc8bb296c</gtr:id><gtr:otherNames>Tripodi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>QcbT5xt8Z52</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B0E26D5-0D44-43A3-82D6-559745DDA073</gtr:id><gtr:title>Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06e91ef0422a15dfdbc713123b72b053"><gtr:id>06e91ef0422a15dfdbc713123b72b053</gtr:id><gtr:otherNames>Goldsworthy M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545a6d902be812.90857438</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D109F7D-9691-4081-B3B9-B02DA9938ADE</gtr:id><gtr:title>Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis.</gtr:title><gtr:parentPublicationTitle>Journal of hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24c89a46bc4fc9d556fe9b4dc2be9826"><gtr:id>24c89a46bc4fc9d556fe9b4dc2be9826</gtr:id><gtr:otherNames>Anstee QM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0168-8278</gtr:issn><gtr:outcomeId>XmbrT4nUbny</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>422227BB-BF07-404A-BC98-772938A750B1</gtr:id><gtr:title>Role of monocytes and macrophages in experimental and human acute liver failure</gtr:title><gtr:parentPublicationTitle>World Journal of Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64e9de8423adca3f31ac8dcbbb045304"><gtr:id>64e9de8423adca3f31ac8dcbbb045304</gtr:id><gtr:otherNames>Possamai L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>5a6f093497e631.19976876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE38D82C-1923-4F76-9D5D-521D66ADC2D1</gtr:id><gtr:title>The importance of fatty liver disease in clinical practice.</gtr:title><gtr:parentPublicationTitle>The Proceedings of the Nutrition Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2b41ed5756913a8115ec4ee278021cd"><gtr:id>b2b41ed5756913a8115ec4ee278021cd</gtr:id><gtr:otherNames>Cobbold JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0029-6651</gtr:issn><gtr:outcomeId>HrNeDPWMkyk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17D3F7CD-6CB0-4A41-81EE-A77AEC8252C6</gtr:id><gtr:title>Parenchymal extinction: coagulation and hepatic fibrogenesis.</gtr:title><gtr:parentPublicationTitle>Clinics in liver disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24c89a46bc4fc9d556fe9b4dc2be9826"><gtr:id>24c89a46bc4fc9d556fe9b4dc2be9826</gtr:id><gtr:otherNames>Anstee QM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1089-3261</gtr:issn><gtr:outcomeId>B33EA9EA904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C0B0B6A-06B3-4D26-934D-B5A5D9C28BD8</gtr:id><gtr:title>Is oil red-O staining and digital image analysis the gold standard for quantifying steatosis in the liver?</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28609652b9b78975d1a672c9abe46ecb"><gtr:id>28609652b9b78975d1a672c9abe46ecb</gtr:id><gtr:otherNames>Levene AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>RXqPcE1MaTt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7386D9E-86B3-427E-883A-8611BEA41BB5</gtr:id><gtr:title>The role of hypercoagulability in liver fibrogenesis.</gtr:title><gtr:parentPublicationTitle>Clinics and research in hepatology and gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24c89a46bc4fc9d556fe9b4dc2be9826"><gtr:id>24c89a46bc4fc9d556fe9b4dc2be9826</gtr:id><gtr:otherNames>Anstee QM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2210-7401</gtr:issn><gtr:outcomeId>N871VCnfWNj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84DBBCAC-30B8-47D3-A94D-3821799C5465</gtr:id><gtr:title>Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24c89a46bc4fc9d556fe9b4dc2be9826"><gtr:id>24c89a46bc4fc9d556fe9b4dc2be9826</gtr:id><gtr:otherNames>Anstee QM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>9C93E7AE60E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E89DE52-E665-4463-99C3-8B7AF1415CE3</gtr:id><gtr:title>Quantifying hepatic steatosis - more than meets the eye.</gtr:title><gtr:parentPublicationTitle>Histopathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/28609652b9b78975d1a672c9abe46ecb"><gtr:id>28609652b9b78975d1a672c9abe46ecb</gtr:id><gtr:otherNames>Levene AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0309-0167</gtr:issn><gtr:outcomeId>pm_12569_29_22372668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75FDB79E-1170-4D53-B441-BED3496F757E</gtr:id><gtr:title>Effect of a thrombin receptor (protease-activated receptor 1, PAR-1) gene polymorphism in chronic hepatitis C liver fibrosis.</gtr:title><gtr:parentPublicationTitle>Journal of gastroenterology and hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e7bc76e326837fc2d0bd283f9f80d51"><gtr:id>5e7bc76e326837fc2d0bd283f9f80d51</gtr:id><gtr:otherNames>Martinelli A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0815-9319</gtr:issn><gtr:outcomeId>33C1328CCAF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54D53735-8FBC-407E-81EB-5A19EF88526B</gtr:id><gtr:title>A missense mutation in the non-neural G-protein alpha-subunit isoforms modulates susceptibility to obesity.</gtr:title><gtr:parentPublicationTitle>International journal of obesity (2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0e7dda135d0624e47df573f6c6c8315"><gtr:id>e0e7dda135d0624e47df573f6c6c8315</gtr:id><gtr:otherNames>Kelly ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0307-0565</gtr:issn><gtr:outcomeId>6EC6177E041</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1C722C3-CD3D-442C-BAF4-60AA806524C2</gtr:id><gtr:title>Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibition.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24c89a46bc4fc9d556fe9b4dc2be9826"><gtr:id>24c89a46bc4fc9d556fe9b4dc2be9826</gtr:id><gtr:otherNames>Anstee QM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>545a6d90a70e91.61403513</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D690F317-2BD1-4CFC-A111-3F2D4171C24E</gtr:id><gtr:title>Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.</gtr:title><gtr:parentPublicationTitle>International journal of experimental pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24c89a46bc4fc9d556fe9b4dc2be9826"><gtr:id>24c89a46bc4fc9d556fe9b4dc2be9826</gtr:id><gtr:otherNames>Anstee QM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0959-9673</gtr:issn><gtr:outcomeId>49ACA76F5B0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F187E7BD-173A-4D4F-8BB6-895E91E1DA62</gtr:id><gtr:title>Genetics of alcoholic and nonalcoholic fatty liver disease.</gtr:title><gtr:parentPublicationTitle>Seminars in liver disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24c89a46bc4fc9d556fe9b4dc2be9826"><gtr:id>24c89a46bc4fc9d556fe9b4dc2be9826</gtr:id><gtr:otherNames>Anstee QM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0272-8087</gtr:issn><gtr:outcomeId>G7tTkZWgBSS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6A47493-3E4A-4936-910D-EB06F26CC536</gtr:id><gtr:title>Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2b41ed5756913a8115ec4ee278021cd"><gtr:id>b2b41ed5756913a8115ec4ee278021cd</gtr:id><gtr:otherNames>Cobbold JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>7063AA6D2A6</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G84/6233</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>